These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38384677)

  • 1. Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case Report.
    Fattore D; Esposito G; Carangelo L; Luciano MA; Megna M
    Case Rep Dermatol; 2024; 16(1):42-46. PubMed ID: 38384677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
    García C; Arellano J; Vera V; Corredoira Y
    Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atezolizumab-induced psoriasis in a patient with metastatic lung cancer-a case report.
    Mao M; Shi M; Li T; Wang Q; Wu L
    Transl Cancer Res; 2020 May; 9(5):3776-3782. PubMed ID: 35117743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma.
    Seervai RNH; Heberton M; Cho WC; Gill P; Murphy MB; Aung PP; Nagarajan P; Torres-Cabala CA; Patel AB; Ruiz-Bañobre J; Om A; Yamamoto T; Nikolaou V; Curry JL
    J Cutan Pathol; 2022 May; 49(5):472-481. PubMed ID: 34888886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Agents for Treating Atezolizumab-Induced Psoriasis in Small-Cell Lung Cancer: A Case Report.
    Fukui M; Chihara Y; Takahashi Y; Sai N; Doi H; Nakakubo Y; Saito M
    Cureus; 2024 May; 16(5):e61395. PubMed ID: 38947665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review.
    Gleason L; Hunter E; Cohen A; Suriano J; Nikbakht N
    Dermatol Online J; 2023 Feb; 29(1):. PubMed ID: 37040912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
    Iijima S; Okazaki Y; Watanabe S; Maruyama Y
    J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy.
    Tadiotto Cicogna G; Messina F; Nalotto L; Szekely S; Alaibac M
    F1000Res; 2019; 8():336. PubMed ID: 31448100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.
    Shi L; Zeng L; Huang X; Wang B; Zhang Y; Zhang G
    Clin Cosmet Investig Dermatol; 2023; 16():951-957. PubMed ID: 37051587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Marginal Keratitis Induced by Atezolizumab, a Programmed Death Ligand 1 Inhibitor for Lung Cancer.
    Yamamoto M; Yamada M; Kusumi Y; Fukui M; Shigeyasu C
    Case Rep Ophthalmol; 2023; 14(1):673-678. PubMed ID: 38058358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PD1/PDL1 induced psoriasis.
    Voudouri D; Nikolaou V; Laschos K; Charpidou A; Soupos N; Triantafyllopoulou I; Panoutsopoulou I; Aravantinos G; Syrigos K; Stratigos A
    Curr Probl Cancer; 2017; 41(6):407-412. PubMed ID: 29096940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
    Nabeshima S; Yamasaki M; Matsumoto N; Takaki S; Nishi Y; Kawamoto K; Taniwaki M; Ohashi N; Hattori N
    Cancer Treat Res Commun; 2021; 26():100270. PubMed ID: 33338849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer.
    Wong PY; How SH; Ismail I; Hassan R
    J Oncol Pharm Pract; 2022 Mar; 28(2):471-474. PubMed ID: 34565238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pustular psoriasis complicated with acute generalized exanthematous pustulosis.
    Abbas M; Holfeld K; Desjardins D; Zimmer J
    J Dermatol Case Rep; 2014 Jun; 8(2):42-5. PubMed ID: 25024776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
    Cirone KD; Lovegrove FE
    SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia.
    Al Nuhait M; Bajnaid E; Al Otaibi A; Al Shammari A; Al Awlah Y
    Sci Prog; 2021; 104(1):36850421997302. PubMed ID: 33689534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.